...
首页> 外文期刊>Journal of Pharmacy and Pharmacology >Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats.
【24h】

Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats.

机译:生姜在链脲佐菌素诱导的I型糖尿病大鼠中的抗糖尿病活性。

获取原文
获取原文并翻译 | 示例
           

摘要

The fresh and dried rhizome of Zingiber officinale Roscoe (commonly known as ginger) is widely used in traditional medicine. We have studied the effect of the juice of Z. officinale (4 mL kg(-1), p.o. daily) for 6 weeks on streptozotocin (STZ)-induced type I diabetic rats with particular reference to the involvement of serotonin (5-hydroxytryptamine; 5-HT) receptors in glycaemic control. In normoglycaemic rats, 5-HT (1mg kg(-1), i.p.) produced hyperglycaemia and hypoinsulinaemia, which was significantly prevented by the juice of Z. officinale. STZ-diabetes produced a significant increase in fasting glucose levels that was associated with a significant decrease in serum insulin levels. Treatment with Z. officinale produced a significant increase in insulin levels and a decrease in fasting glucose levels in diabetic rats. In an oral glucose tolerance test, treatment with Z. officinale was found to decrease significantly the area under the curve of glucose and to increase the area under the curve of insulin in STZ-diabetic rats. Treatment with Z. officinale also caused a decrease in serum cholesterol, serum triglyceride and blood pressure in diabetic rats. Our data suggest a potential antidiabetic activity of the juice of Z. officinale in type I diabetic rats, possibly involving 5-HT receptors.
机译:新鲜和干燥的姜姜根茎(俗称生姜)被广泛用于传统医学中。我们已经研究了Z.officinale汁(4 mL kg(-1),每天口服)6周对链脲佐菌素(STZ)诱导的I型糖尿病大鼠的影响,特别涉及5-羟色胺(5-羟色胺; 5-HT)受体可控制血糖。在正常血糖大鼠中,5-HT(1mg kg(-1),i.p.)会产生高血糖和低胰岛素血症,这可以通过Z.officinale的汁液来明显预防。 STZ糖尿病使空腹血糖水平显着升高,这与血清胰岛素水平显着下降有关。 Z. officinale的治疗在糖尿病大鼠中产生了胰岛素水平的显着升高和空腹血糖水平的降低。在口服葡萄糖耐量试验中,发现用Z.officinale处理可显着降低STZ糖尿病大鼠的葡萄糖曲线下面积,并增加胰岛素曲线下面积。 Z. officinale的治疗还导致糖尿病大鼠的血清胆固醇,血清甘油三酯和血压降低。我们的数据表明,Z.officinale汁在I型糖尿病大鼠中可能具有抗糖尿病活性,可能涉及5-HT受体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号